Literature DB >> 4540250

(S)-norepinephrine in the tissues of mice and rats given racemic erythro-3,4-dihydroxyphenylserine (DOPS).

C C Porter, M L Torchiana, C A Stone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4540250     DOI： 10.1016/0024-3205(72)90213-5

Source DB:  PubMed          Journal:  Life Sci I        ISSN： 0300-9653


× No keyword cloud information.
  4 in total

Review 1.  Amine precursor amino acid therapy: from neurochemical basis to clinical aspects.

Authors:  T Nakajima
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

2.  Reversal of the reserpine-induced ptosis by L-threo-3,4-dihydroxy-phenylserine (L-threo-DOPS), a (-)-norepinephrine precursor, and its potentiation by imipramine or nialamide.

Authors:  T Kato; M Katsuyama; N Karai; A Hirose; M Nakamura; J Katsube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-03       Impact factor: 3.000

3.  Formation of noradrenaline in the rat brain from the four stereoisomers of 3,4-dihydroxyphenylserine.

Authors:  M Puig; G Bartholini; A Pletscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  Memory effect of DL-threo-3,4-dihydroxyphenylserine (DOPS) in human Korsakoff's disease.

Authors:  P J Langlais; R G Mair; P J Whalen; W McCourt; W J McEntee
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.